Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E5501 food-effect and lot-comparison pharmacokinetics study in healthy adults
NL-OMON36548Active, not recruiting
- Sponsor
- Eisai Co., Ltd.
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of avatrombopag in Thrombocytopenia, immune thrombocytopenia (ITP), thrombocytopenia associated with chronic liver disease and 1 more (4 arms), sponsored by Eisai Co., Ltd. Primary endpoints: Plasma E5501 concentrations, Area under the plasma concentration-time curve (AUC) and 7 more. Started Feb 2011; status: active, not recruiting.
02
Drugs
avatrombopag
03
Conditions
Thrombocytopeniaimmune thrombocytopenia (ITP)thrombocytopenia associated with chronic liver diseasechemotherapy-induced thrombocytopenia (CIT)
Beyond the preview
Go deeper on NL-OMON36548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36548.